MA41574A1 - Pde9 inhibitors having an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases - Google Patents
Pde9 inhibitors having an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseasesInfo
- Publication number
- MA41574A1 MA41574A1 MA41574A MA41574A MA41574A1 MA 41574 A1 MA41574 A1 MA 41574A1 MA 41574 A MA41574 A MA 41574A MA 41574 A MA41574 A MA 41574A MA 41574 A1 MA41574 A1 MA 41574A1
- Authority
- MA
- Morocco
- Prior art keywords
- backbone
- imidazo
- treatment
- triazinone
- pyrazinone
- Prior art date
Links
- 229940076380 PDE9 inhibitor Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- MPWOBEOETVOESI-UHFFFAOYSA-N imidazo[4,5-b]pyrazin-2-one Chemical group N1=CC=NC2=NC(=O)N=C21 MPWOBEOETVOESI-UHFFFAOYSA-N 0.000 title 1
- IJYHVZICHKCLMQ-UHFFFAOYSA-N imidazo[4,5-d]triazin-4-one Chemical group O=C1N=NN=C2N=CN=C12 IJYHVZICHKCLMQ-UHFFFAOYSA-N 0.000 title 1
- 230000002093 peripheral effect Effects 0.000 title 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000007056 sickle cell anemia Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des inhibiteurs de pde9 et leur utilisation pour le traitement de l'hyperplasie bénigne de la prostate et de la drépanocytose.The present invention relates to inhibitors of pde9 and their use for the treatment of benign prostatic hyperplasia and sickle cell disease.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201500393 | 2015-07-07 | ||
| PCT/EP2016/065964 WO2017005786A1 (en) | 2015-07-07 | 2016-07-06 | Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA41574A1 true MA41574A1 (en) | 2018-07-31 |
| MA41574B2 MA41574B2 (en) | 2021-09-30 |
Family
ID=63639456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA41574A MA41574B2 (en) | 2015-07-07 | 2016-07-06 | Pde9 inhibitors with an imidazo triazinone backbone and an imidazo pyrazinone backbone for the treatment of peripheral diseases |
Country Status (1)
| Country | Link |
|---|---|
| MA (1) | MA41574B2 (en) |
-
2016
- 2016-07-06 MA MA41574A patent/MA41574B2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA41574B2 (en) | 2021-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2017000507A1 (en) | Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases | |
| JOP20220083A1 (en) | Bicyclic heterocycles as fgfr inhibitors | |
| EA201690746A1 (en) | TREATMENT WITH THE USE OF BLUTON AND IMMUNOTHERAPY THYROZINKINASE INHIBITORS | |
| TN2019000099A1 (en) | ANTI-LAG-3 ANTIBODIES AND COMPOSITIONS | |
| MX375752B (en) | BRUTON'S TYROSINE KINASE INHIBITORS. | |
| MX2017001671A (en) | Novel formulations of a bruton's tyrosine kinase inhibitor. | |
| EA201290894A1 (en) | AZETIDINE DERIVATIVES OF PIPERIDIN-4-ILA AS JAK1 INHIBITORS | |
| UA120065C2 (en) | 4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS | |
| MX2017015574A (en) | Inhibitors of bruton's tyrosine kinase. | |
| EA201691114A1 (en) | BIARRYLIC CONNECTIONS USED IN THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEPHROLOGY AND IMMUNOLOGY | |
| MA38183A1 (en) | Pyrrolopyrimidine compounds as kinase inhibitors | |
| EA201500393A1 (en) | BLUTON TYROSINKINASE INHIBITORS | |
| EA201270100A1 (en) | Pyrimidinones as PI3K inhibitors | |
| TW201613919A (en) | Inhibitors of Bruton's tyrosine kinase | |
| MX383213B (en) | TYROSINE KINASE INHIBITORS | |
| MX394784B (en) | PHARMACEUTICAL COMPOSITIONS OF A BRUTON TYROSINE KINASE INHIBITOR. | |
| EA201100426A1 (en) | BICYCLIC KINASE INHIBITORS | |
| EA201792304A1 (en) | COMBINED THERAPY FOR CANCER TREATMENT | |
| MA38284B1 (en) | Inhibitors of 2,3-dihydroimidazol [1,2-c] pyrimidin-5 (1 h) -one-2-lipoprotein-associated phospholipase (lp-pla2) | |
| MA38827A1 (en) | Combination of a mek inhibitor and an erk inhibitor for use in the treatment of hyperproliferative diseases | |
| EA201300871A1 (en) | DERIVATIVES (1,2,4) TRIAZOLO [4,3-a] CHINOXALINE AS PHOSPHODYESTERES INHIBITORS | |
| FR3084254B1 (en) | LANIFIBRANOR DERIVATIVES | |
| BR112018006135A2 (en) | fused pyrazole derivatives as kinase inhibitors | |
| MX2023000191A (en) | Methods of making and using pde9 inhibitors. | |
| MX2019010173A (en) | Csf1r-based chimeric proteins. |